Status:

ENROLLING_BY_INVITATION

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

Lead Sponsor:

University of Giessen

Conditions:

Hypertension, Pulmonary

Hypertension;Pulmonary;Primary

Eligibility:

All Genders

18+ years

Brief Summary

Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for t...

Detailed Description

The disease pulmonary hypertension is due to a remodeling of the lung vessels which results in a change of the exhaled air. This change is measurable with a so called capnograph. The investigators wan...

Eligibility Criteria

Inclusion

  • Age \> 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart catheterization

Exclusion

  • none

Key Trial Info

Start Date :

May 2 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2035

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT03388476

Start Date

May 2 2018

End Date

January 1 2035

Last Update

May 19 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Clinic Giessen and Marburg

Giessen, Hesse, Germany, 35392